Registration fees for webinars are $175/member and $300/non-member
unless otherwise noted in event description.
Free Webinar: Performance Healthcare Solutions
2:00 PM - 3:00 PM
HSIsolutions | NDHA has recently endorsed Performance Healthcare Solutions (PHS) and is hosting a webinar for three very specific and valuable solutions for our membership. The first is the RXPool PBM Savings Solution which provides hospitals with a great opportunity to save a sizeable amount of money on their annual Employee Drug Benefit spend. This solution gives smaller hospital organizations the opportunity to join a national aggregation of hospital employee and dependent lives in order to create tremendous leverage to negotiate with PBM’s for a significant savings on the member’s annual drug spend.
The second opportunity is with PHS’s 340B Enhanced: Referral Capture Solution which is an enhancement to a hospital’s existing 340B program. This solution allows covered entities to increase their 340B revenue by, on average, 20%. This solution does not require a hospital to change administrators, but simply identifies high dollar referral scripts that are not captured by the hospitals existing administrator. This solution is designed to bring additional dollars to PHS clients in a compliant manner and only takes weeks to implement.
The third opportunity is a 340B consolidator and self-auditing technology. This system consolidates situations where a hospital has to utilize multiple administrators and brings all of the information and reporting into one point of view. This allows the hospital to manage and report from one system vs. multiple systems. The self-auditing portion of the system allows the hospital to customize its policies and procedures on self-auditing into the technology so that their audits can be run automatically. The system not only audits compliance but also audits inventory replenishment, financial reconciliation and the drug purchase price compared to the 340B price. The purchase price comparison historically saves hospitals 1-5% in drug overcharges annually.